The North America Blood Collection Devices Market was valued at USD 3,045 Million in 2025 and is expected to reach USD 5,420 Million by 2035, growing at a CAGR of 5.4% from 2024 to 2035. This growth is driven by technological advancements, rising demand for safe blood collection, and increasing chronic diseases across the region.
The economic impact of tariffs on "North America Blood Collection Devices Market".
North America Blood Collection Devices Market Growth Drivers
Rising incidence of chronic diseases, such as diabetes, cardiovascular disorders, and cancer, has led to increased demand for blood collection for diagnostic purposes. Becton, Dickinson and Company (BD), a leading player, has seen a surge in demand for its advanced blood collection products, as healthcare providers aim to improve early diagnosis and personalized care.
Technological innovations in blood collection devices, such as the introduction of closed blood collection systems and needle safety technologies, are propelling market growth. Companies like Terumo Corporation have launched new safety-engineered blood collection sets that minimize the risk of needlestick injuries for healthcare workers, aligning with stringent OSHA safety guidelines.
North America Blood Collection Devices Market Trends
Adoption of digital and automated blood collection systems is accelerating, driven by the need for efficiency and reduced manual errors. Companies such as Greiner Bio-One have introduced automated systems that streamline blood collection in large hospital settings, leading to reduced turnaround times and improved workflow.
There is an increasing adoption of sustainable and eco-friendly blood collection devices. Market leaders like Sarstedt AG & Co have begun offering products manufactured from recyclable materials, in response to the growing pressure for sustainable medical device production and disposal.
North America Blood Collection Devices Market Opportunities
Expansion into decentralized and home-based blood collection services represents a major opportunity, given the rise in telehealth and remote patient monitoring. Companies such as Quest Diagnostics are piloting home blood collection kits to provide convenience and expand service reach.
Partnerships with digital health platforms to integrate blood collection data into electronic health records (EHR) offer growth potential. For example, LabCorp is collaborating with digital health startups to streamline patient data integration and analysis.
North America Blood Collection Devices Market Revenue (USD Million), 2020-2035
The market revenue has shown steady growth from 2020 to 2035. In 2020, the market was valued at USD 2,100 Million and by 2025, it reached USD 3,045 Million. Accelerated by increased healthcare investments and advancements in device safety, the market is projected to hit USD 5,420 Million by 2035. The chart demonstrates a consistent upward trend, indicating robust long-term prospects. Notably, years 2027-2035 are expected to experience compounded annual growth, as both government initiatives and private innovations drive market expansion across North America.
North America Blood Collection Devices Market by Region Share (%) - 2025
As of 2025, the United States commands the dominant market share at 77%, primarily due to its advanced healthcare infrastructure and significant healthcare spending. Canada accounts for 16% of the market, driven by its universal healthcare system and emphasis on diagnostic services. Mexico contributes 5%, while Central America and the Caribbean collectively represent 2%. This distribution highlights the significant disparity in healthcare investment and technology adoption across North America, favoring the U.S. as a leader in blood collection devices innovation and usage.
Recent Developments in North America Blood Collection Devices Market (Last 6 Months)
In February 2024, BD (Becton, Dickinson and Company) received FDA clearance for its BD Vacutainer UltraTouch blood collection set, developed to improve patient comfort and reduce the risk of hemolysis and sample contamination. This device incorporates advanced needle design and material innovations for optimal sample integrity.
In April 2024, Terumo Corporation announced a partnership with Mayo Clinic to pilot AI-driven blood collection system integration in clinical laboratories. The focus is on enhancing workflow management, reducing errors, and optimizing phlebotomy practices through data analytics.
In March 2024, Greiner Bio-One launched its MiniCollect capillary blood collection tubes in North America, targeting pediatric and geriatric segments. The new tubes utilize eco-friendly plastics and support small-volume sampling, addressing sustainability goals and patient-specific collection requirements.
Press Releases